ArticleBMC pediatrics2026
RSV bronchiolitis versus COVID-19: could pediatric intensive care units have done more during the pandemic?
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COronaVirus Disease 2019 (COVID-19) pandemic disproportionately overwhelmed adult critical care resources. It also led to a reduction of pediatric intensive care unit (PICU) admissions due to the significant attenuation of respiratory syncytial virus (RSV) epidemics. We compared RSV bronchiolitis with pediatric COVID-19 admissions in the context of accepting adult ICU patients to our PICU during the pandemic.
methodsThis retrospective study compared pediatric patients admitted to the PICU with bronchiolitis and a COVID-19 infection between November 2019 to March 2023 inclusive. These two cohorts were considered with allcomers and adult patients admitted to the PICU between June 2020 and December 2021.
resultsOne hundred and twenty-six patients with RSV bronchiolitis were compared with 35 pediatric patients with COVID-19. There were zero and 14 RSV admissions during the winters of 2020-21 and 2021-22, respectively. The COVID-19 cohort had higher acuity, C- reactive protein, conventional mechanical ventilation requirements and mortality. The PICU averaged 47.9 PICU admissions per month during the pandemic. There were no differences in monthly PICU admissions when adults were or were not admitted (mean 44.0 versus 49.4; p = 0.16).
conclusionWhile COVID-19 disproportionately burdened adult ICU resources, the RSV epidemic was disrupted for two winters. Consequently, our vacant PICU beds were used to support adult ICU surges while maintaining below baseline admission rates. This suggests that our PICU may have had the capacity to absorb more ICU patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.